feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    UID:
    gbv_1023440326
    Format: 1 Online-Ressource (vii, 326 p) , ill
    ISBN: 9781849805513
    Series Statement: Edward Elgar E-Book Archive
    Content: This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book
    Content: pt. 1. Firms, networks and business models -- pt. 2. The rise of biotechnology : new foundations for biopharmaceuticals -- pt. 3. Responding to the new knowledge base : diverse business models -- pt. 4. Four case studies -- pt. 5. Value creation and capture : implications
    Note: Includes bibliographical references (p. 290-311) and index
    Additional Edition: ISBN 9781848447172 (hardback)
    Additional Edition: ISBN 9781847209498
    Additional Edition: Available in another form ISBN 9781847209498
    Additional Edition: Erscheint auch als Druck-Ausgabe Rasmussen, Bruce Innovation and commercialisation in the biopharmaceutical industry Cheltenham : Elgar, 2010 ISBN 1848447175
    Additional Edition: ISBN 9781848447172
    Language: English
    Subjects: Economics
    RVK:
    Keywords: Biopharmazie ; Innovation ; Geschäftsidee ; Biotechnologie ; Innovation ; Geschäftsidee
    URL: Volltext  (Deutschlandweit zugänglich)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    almahu_9947914935502882
    Format: 1 online resource (vii, 326 p.) : , ill.
    ISBN: 9781849805513 (e-book)
    Content: This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book.
    Note: pt. 1. Firms, networks and business models -- pt. 2. The rise of biotechnology : new foundations for biopharmaceuticals -- pt. 3. Responding to the new knowledge base : diverse business models -- pt. 4. Four case studies -- pt. 5. Value creation and capture : implications.
    Additional Edition: ISBN 9781847209498
    Additional Edition: ISBN 9781848447172 (hardback)
    Language: English
    Keywords: Electronic books. ; Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    UID:
    almafu_BV026777525
    Format: VII, 326 S. : , graph. Darst.
    ISBN: 978-1-84844-717-2
    Language: English
    Subjects: Economics
    RVK:
    Keywords: Pharmazeutische Industrie ; Biologika ; Arzneimittelforschung ; Produktinnovation ; Vermarktung ; Wettbewerbsstrategie ; Strategische Allianz ; Spitzentechnologie ; Wissenschaftstransfer ; Spin-off-Unternehmensgründung ; Entrepreneurship ; Internationaler Vergleich ; Spitzentechnologie ; Entrepreneurship ; Unternehmensgründung ; Unternehmensentwicklung ; Aufsatzsammlung
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    b3kat_BV046662028
    Format: 1 Online-Ressource (vii, 326 Seiten) , Illustrationen
    ISBN: 9781849805513
    Content: This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book
    Content: pt. 1. Firms, networks and business models -- pt. 2. The rise of biotechnology : new foundations for biopharmaceuticals -- pt. 3. Responding to the new knowledge base : diverse business models -- pt. 4. Four case studies -- pt. 5. Value creation and capture : implications
    Note: Includes bibliographical references (p. 290-311) and index
    Additional Edition: Erscheint auch als Druck-Ausgabe, Hardcover ISBN 9781848447172
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 9781847209498
    Language: English
    Subjects: Economics
    RVK:
    RVK:
    Keywords: Pharmazeutische Industrie ; Biologika ; Arzneimittelforschung ; Produktinnovation ; Vermarktung ; Wettbewerbsstrategie ; Strategische Allianz ; Spitzentechnologie ; Wissenschaftstransfer ; Spin-off-Unternehmensgründung ; Entrepreneurship ; Internationaler Vergleich ; Spitzentechnologie ; Entrepreneurship ; Unternehmensgründung ; Unternehmensentwicklung ; Aufsatzsammlung
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    UID:
    b3kat_BV048635341
    Format: 1 Online-Ressource (vii, 326 Seiten) , ill
    ISBN: 9781849805513
    Series Statement: Edward Elgar E-Book Archive
    Content: pt. 1. Firms, networks and business models -- pt. 2. The rise of biotechnology : new foundations for biopharmaceuticals -- pt. 3. Responding to the new knowledge base : diverse business models -- pt. 4. Four case studies -- pt. 5. Value creation and capture : implications
    Content: This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book
    Note: Includes bibliographical references (p. 290-311) and index
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 9781847209498
    Additional Edition: ISBN 9781848447172
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    UID:
    kobvindex_INTNLM010890556
    Format: 1 online resource (vii, 326 p) , ill
    ISBN: 9781849805513
    Series Statement: Edward Elgar E-Book Archive
    Content: part 1. Firms, networks and business models -- part 2. The rise of biotechnology : new foundations for biopharmaceuticals -- part 3. Responding to the new knowledge base : diverse business models -- part 4. Four case studies -- part 5. Value creation and capture : implications
    Content: This path-breaking book addresses the ongoing implications for traditional pharmaceutical companies and biopharmaceutical start-ups of the realignment of the industry knowledge-base. The theoretical approach draws on the modern theory of the firm and related ideas in order to better define the concept of the business model, which is employed to guide the case studies and empirical analysis in the book
    Note: Includes bibliographical references (pages 290-311) and index
    Additional Edition: Available in another form ISBN 9781847209498
    Additional Edition: ISBN 9781848447172(hardback)
    Additional Edition: ISBN 9781847209498
    Additional Edition: ISBN 9781848447172
    Language: English
    URL: FULL  ((Currently Only Available on Campus))
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages